Results

Patient Description
The patient, a 14-year-old boy, had been referred to our department because of Asperger syndrome and chronic fatigue. He was the first child of healthy, non-consanguineous parents, born after an uneventful pregnancy and delivery at 40 weeks of gestation with a weight of 3,220 g (30th centile). He developed normally. He could sit at the age of 5.5 months, walk at the age of 1 year, and said his first words appropriately for age. Before the age of 6 years, behavioral problems became evident. He showed obsessive behavioral patterns, such as repeated on and off switching of light and hiding of keys. Moreover, he often rocked back and forth and had difficulty adjusting to unexpected situations. At the age of 6 years, his parents took him to a child and adolescent psychiatrist, who subsequently diagnosed him with Asperger syndrome. The patient followed normal education, though with some extra coaching. His intelligence quotient (IQ) was estimated to be 102 (WISC-III), although there was a discrepancy between his verbal IQ (109) and performance IQ (94). At the age of 12 years, the patient sought medical help due to chronic fatigue. He also complained of myalgia and pain in his legs. Extensive clinical and laboratory investigations, including metabolic disease screening, were normal. The fatigue symptoms were so severe that the patient was referred for an inpatient rehabilitation program. He was discharged after 9 weeks of rehabilitation and transferred to a special secondary school for children with physical disabilities. At the age of 14 years, the patient had returned to a normal school curriculum, though he was still functioning at a lower academic level than he used to do. His further medical history revealed no abnormalities. He had a normal sleeping pattern, normal hearing and vision, and he used to take part in normal sports activities, without any restrictions.
Physical examination performed at the age of 14 years showed a length of 186 cm (98th centile), a weight of 95 kg (+2.5 SD), and a head circumference of 61 cm (98th centile). There were no facial dysmorphisms, except for a broad nasal base (see fig. 1 a) . The muscle strength was normal, despite the poor physical condition.
The patient had a younger brother who developed normally. His father was 184 cm (50th centile) with a head circumference of 58 cm (50th centile). His mother was 173 cm (70th centile) with a head circumference of 57 cm (85th centile). A son of a paternal aunt was diagnosed with pervasive developmental disorder not otherwise specified, and a female second cousin on the paternal side (part of a large family) was also diagnosed with Asperger syndrome.
SNP array analysis revealed an interstitial gain in band p22.3 of chromosome 7 with a minimal size of 380 kb (18 SNPs, 2.26-2.64 Mb from the p-telomere, SNP_A-2194214 to SNP_A-2107081) and a maximal size of 450 kb (2.23-2.68 Mb from the p-telomere, SNP_A-1914583 to SNP_A-1785979) (NCBI Genome Build 37/ Hg19) ( fig. 1 b) . The duplicated region contains at least 9 known RefSeq genes, namely MAD1L1 , FTSJ2 , NUDT1 , SNX8 , EIF3B , CHST12 , LFNG , BRAT1 , and IQCE ( fig. 1 c) . The absence of the same gain in the SNP array analyses of DNA from the parents revealed that the gain had occurred de novo in their son.
Discussion
We describe a de novo gain in 7p22.3 in a patient with Asperger syndrome. This region has never been associated with ASDs previously [Risch et al., 1999; Szatmari et al., 2007; Yang and Gill, 2007; Glessner et al., 2009; Pinto et al., 2010; Sanders et al., 2011] . In the Decipher (http:// decipher.sanger.ac.uk/) and ECARUCA (www.ecaruca. net) databases only much larger overlapping aberrations have been described that are usually part of complex rearrangements in patients with primarily intellectual disability (ID) [Feenstra et al., 2006; Firth et al., 2009] .
In healthy control persons 2 overlapping duplications of the 7p22 region have been described in the Study of Addiction: Genetics and Environment (SAGE, http:// zork.wustl.edu/gei/) and the study by Park et al. [2010] . Although the controls of the SAGE study have been selected to be not addicted, ASDs were not excluded in these controls. The latter is similar for the study by Park et al. [2010] . In a recent study on autism by Sanders et al. [2011] , 2 partially overlapping duplications have been found in healthy parents that were not present in their own autistic children. These duplications contained the genes MAD1L1 , FTSJ2 , NUDT1 , SNX8 , and EIF3B . However, the duplicated region in our patient contained 4 additional known RefSeq genes, namely CHST12 , LFNG , BRAT1 , and IQCE .
The most likely candidate gene for ASDs is LFNG , or lunatic fringe. In animal models, Lfng is essential for the demarcation of boundaries between groups of cells during development, for example in dorsoventral patterning of the Drosophila wing, the hindbrain and the somites [Irvine and Wieschaus, 1994; Johnston et al., 1997; Zeltser et al. Tossell et al., 2011] . In humans an autosomal recessive mutation in LFNG has been detected in a family with spondylocostal dysostosis, a vertebral malsegmentation disorder [Sparrow et al., 2006] . In the developing brain, Lfng is particularly expressed in the ventricular zone of the neuroepithelium where neurogenesis takes place [Johnston et al., 1997; Ishii et al., 2000] . LFNG is a glycosyltransferase that modulates the activity of the Notch signaling pathway [Panin et al., 1997; Moloney et al., 2000; Stanley and Okajima, 2010] . During neural development Notch plays an essential role in the regulation of cell fate choice through lateral inhibition [Cau and Blader, 2009] . It effectuates the maintenance of neuronal progenitors and the inhibition of neuronal differentiation in the ventricular zone [Yoon and Gaiano, 2005; Louvi and Artavanis-Tsakonas, 2006] . Both loss-of-function of lfng in zebrafish and Notch1 in mice leads to an early increase in the number of differentiating neurons leading to a reduction in the size of brain structures as a result of secondary progenitor pool depletion [Lutolf et al., 2002; Yoon and Gaiano, 2005; Nikolaou et al., 2009 ], while overexpression results in an increase of neuronal progenitor cells at the expense of differentiating cells [Gaiano et al., 2000; Breunig et al., 2007; Li et al., 2008; Nikolaou et al., 2009; Kato et al., 2010] . The latter may in turn result in an enlargement of brain structures [de Bellard et al., 2007] . Interestingly, ASDs are associated with an enlarged brain volume (and head circumference) [Kanner, 1943; Piven et al., 1995; Woodhouse et al., 1996] . One of the possible mechanisms to explain this increase in brain volume is an increase in neuron number [Vaccarino et al., 2009; Rubenstein, 2011] . Therefore, activation of the Notch signaling pathway might be an interesting candidate mechanism for the ASD in our patient. This is supported by the large head circumference that was present in the patient, but not in his parents. Besides, the Notch signaling pathway has been previously described to be differentially expressed in patients with ASDs [Seno et al., 2011] . In addition, a causal link with the Notch signaling pathway has been hypothesized in other psychiatric diseases, including schizophrenia, and cognition [Costa et al., 2005; Wang et al., 2006] . Therefore, it seems probable that an increased dosage of LFNG through this duplication may result in an increased brain volume and an enlarged head circumference. This may have predisposed the patient to an ASD. Of the other 8 genes that were duplicated in the patient, 3 could also be possible candidates for Asperger syndrome, namely IQCE , FTSJ2 , and EIF3B . A related gene of these 3 genes has previously been associated with a neurobehavioral phenotype. IQCE contains an IQ domain [Rhoads and Kenguele, 2005] , while IQSEC2 , another IQ domain containing protein, is a known X-linked ID gene [Shoubridge et al., 2010] . The homolog of FTSJ2, FTSJ1 , is also a known gene for nonsyndromic X-linked ID [Freude et al., 2004; Ramser et al., 2004] . In addition, duplications of Xp11.22-p11.23, including FTSJ1 , have been described in patients with ID, autistic behavior and seizures. However, autistic features have also been described in patients with smaller duplications that do not overlap FTSJ1 [El-Hattab et al., 2011] . EIF3B encodes for a subunit of one of the family members of the eukaryotic initiation factors that regulate mRNA translation [Maitra et al., 1982; Hinnebusch, 2006] . Deregulation of EIF4E expression, another family member of the eukaryotic initiation factors, has been described in patients with severe autism [Neves-Pereira et al., 2009] , while EIF2B subunit mutations are found in patients with vanishing white matter [Leegwater et al., 2001] . Besides, EIF3 has recently been shown to interact with collybistin ( ARHGEF9 in humans) and gephyrin, 2 postsynaptic proteins [Sertie et al., 2010] . Defects in synaptic function have already been implicated in the pathogenesis of autism [Sudhof, 2008; van Spronsen and Hoogenraad, 2010] .
However, 2 partially overlapping duplications have already been found in healthy parents of an autistic child (and not in the child itself) as mentioned before. One of these duplications encompasses both FTSJ2 and EIF3B , which makes their relation to this phenotype less likely. Being that both IQSEC2 and FTSJ1 have been described in ID, while our patient had Asperger syndrome with a normal IQ, this attenuates a possible link between the related genes IQCE and FTSJ2 and the phenotype of our patient. Finally, most of these genes cause these diseases by a loss-of-function mechanism, while a duplication was found in this patient.
Two family members on the father's side of the family of the patient also have an ASD. As the prevalence of ASDs is known to be high (in the range of 6-7 per 1,000) [Fombonne, 2009] , this might be due to a coincidence. However, ASDs are known to be complex genetic disorders [Folstein and Rosen-Sheidley, 2001 ]. It has been hypothesized that for ASDs multiple mutations together reach a certain threshold in order to result in the clinical phenotype. It is therefore possible that an increased background risk for the development of an ASD was already present in the patient's family. The gain in 7p22.3 may then be only a contributing factor to the development of Asperger syndrome. This is in line with the finding of a small CNV including LFNG and the neighboring BRAT1 in an anonymous healthy Asian female by Park et al. [2010] . Nevertheless, being that the gain in 7p22.3 occurred de novo in the patient, while his parents were healthy, without any signs of ASDs, a causal link with his phenotype could be postulated.
In conclusion, we describe a de novo submicroscopic gain in 7p22.3 in a patient with Asperger syndrome. We suggest that this CNV, which encompasses 9 genes including LFNG, has been a possible contributive factor to the occurrence of Asperger syndrome in this patient.
